GLP-1 Weight Loss in Albuquerque: Lower Obesity Than the Rest of New Mexico, but No Local Clinic Will Quote a Price
Albuquerque's below-state obesity rate, a low-income HPSA covering 225,454 people inside the state's best-resourced city, UNM as the rural specialist backstop, and three price-opaque providers.
Albuquerque's adult obesity prevalence is 32.9% crude (CDC PLACES 2025 release, BRFSS 2023), with Bernalillo County co-published at 33.0% in the same release 12, both below New Mexico's statewide 34.5% 3. The state's best-resourced city is not its heaviest.
It still has 560,333 residents in a 929,919-person metro where 9.1% carry no insurance and median household income is $71,494 4567. Three local GLP-1 providers were checked and none publishes a price 111213.
Bernalillo County carries an active HRSA Primary Care Health Professional Shortage Area designation for its low-income population (score 18, an estimated 225,454 people) and a parallel low-income Mental Health HPSA (score 19, about 218,053 people) — a population-group designation, not a shortage across the whole county, meaning low-income residents specifically lack adequate access even inside New Mexico's best-resourced city. Nine additional facility-specific HPSAs sit on top of that, at Albuquerque's federally qualified health centers (First Nations Community Healthsource and its Central and Truman sites, First Choice Community Health Care, Albuquerque Health Care for the Homeless) and at IHS and tribal facilities (Albuquerque Indian Health Center, Albuquerque Indian Dental Clinic, Isleta Health Center, Canoncito Health Center). Albuquerque is not a full geographic primary-care shortage area — but its low-income, homeless, and Native American residents are, in HRSA's own designations. A meaningful share of the city's population doesn't have the standing primary-care relationship that GLP-1 prescribing and monitoring usually run through.910
Specialist access
HRSA's HPSA program scores shortages in primary care, dental, and mental health only — it does not track endocrinology or obesity medicine, so there is no federal shortage designation for GLP-1-prescribing specialists in Albuquerque. The University of New Mexico Health Sciences Center is the state's main academic referral center for endocrinology and functions as the de facto specialist backstop for rural New Mexico, but no verified count of local endocrinologists, wait times, or new-patient availability could be sourced for Albuquerque. That is recorded here as a data gap, not an estimate.9
Medicaid coverage note
9.1% of Albuquerque residents have no health insurance (ACS 2024 1-year estimates, table B27001: 50,518 of 555,836 civilian noninstitutionalized residents). A separate 45.4% of the city carries some public coverage — Medicare, Medicaid, or other means-tested insurance combined (ACS 2024 1-year, table B27003: 252,132 of 555,836) — but that figure includes Medicare-age seniors, so it isn't a Medicaid-specific enrollment rate. Whether New Mexico Medicaid covers semaglutide or tirzepatide for a weight-loss, non-diabetes indication was not independently verified for this page and is recorded as a data gap rather than assumed. Nationally, state Medicaid programs typically exclude anti-obesity medications even when they cover the same drugs for diabetes, which is the standard reason cash-pay telehealth models serve this population regardless of insurance status.
Nearly half the city holds public coverage; the GLP-1 answer isn't published
9.1% of Albuquerque residents have no health insurance, 50,518 of 555,836 civilian noninstitutionalized residents per ACS 2024 1-year table B27001 7. A separate 45.4% of the city carries some public coverage, Medicare, Medicaid, or other means-tested insurance combined, 252,132 of 555,836 per table B27003 8. That figure includes Medicare-age seniors, so it is not a Medicaid enrollment rate.
Whether New Mexico Medicaid covers semaglutide or tirzepatide for a weight-loss, non-diabetes indication was not independently verified for this page and is recorded as a data gap rather than assumed. Nationally, state Medicaid programs typically exclude anti-obesity medications even while covering the same drugs for diabetes, which is the standard reason a cash-pay model serves this population regardless of insurance status.
What GLP-1 care costs in Albuquerque today
Enhanced Wellness NM at 5200 Eubank Blvd NE, Suite C-3 markets a named "GLP-1 Weight Support Program" and states on the service page: "Cost depends on the specific medication, dosing, and how much ongoing monitoring is part of your plan. Our team can walk you through current pricing during your consultation." No semaglutide or tirzepatide figure appears anywhere on the site 11.
Reform ABQ at 200 Oak St NE, Unit 7, a direct primary care practice, advertises "GLP-1 and GIP medication programs with personalized nutrition guidance, lifestyle coaching, and ongoing monitoring" and publishes no price, directing visitors to call or email 12. Sono Bello at 5601 Office Blvd NE, Suite 200 markets "Post GLP-1 Weight Loss Support," body contouring after weight loss rather than GLP-1 prescribing, and lists no medication price; it is included as evidence that GLP-1-adjacent demand exists here, not as a comparable prescriber 13.
Astra's price is published and flat everywhere it treats: $68/month for compounded semaglutide and $118/month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416. That is the same number in Albuquerque as in every other state Astra serves, with no local rate and no consult required to see it.
A population-group shortage inside the state's best-resourced city
Bernalillo County carries an active Primary Care HPSA for its low-income population, score 18, covering an estimated 225,454 people, and a parallel low-income Mental Health HPSA, score 19, covering about 218,053 910. This is a population-group designation, not a county-wide one: low-income residents specifically lack adequate access even here.
Nine additional facility-specific HPSAs sit on top of that, at First Nations Community Healthsource and its Central and Truman sites, First Choice Community Health Care, Albuquerque Health Care for the Homeless, and at IHS and tribal facilities including the Albuquerque Indian Health Center, Albuquerque Indian Dental Clinic, Isleta Health Center, and Canoncito Health Center 910. A meaningful share of the city lacks the standing primary-care relationship that GLP-1 prescribing and monitoring usually run through.
The University of New Mexico Health Sciences Center is the state's main academic endocrinology referral center and the de facto backstop for rural New Mexico, but no verified count of local endocrinologists, wait times, or new-patient availability could be sourced, and none is estimated here. Telehealth does not require an existing PCP relationship or a UNM referral. Astra serves all 50 states, including New Mexico.
Astra treats patients in New Mexico through state-licensed physicians.
Local options
Enhanced Wellness NM — 5200 Eubank Blvd NE, Suite C-3, Albuquerque, NM 87111. Markets a named 'GLP-1 Weight Support Program' alongside IV and peptide wellness services. The service page states: 'Cost depends on the specific medication, dosing, and how much ongoing monitoring is part of your plan. Our team can walk you through current pricing during your consultation.' No semaglutide or tirzepatide dollar figure is published anywhere on the site. https://enhancedwellnessnm.com/services/glp-1-weight-support-program-in-albuquerque-nm/(checked 2026-08-28)
Reform ABQ — 200 Oak St NE, Unit 7, Albuquerque, NM 87106. A direct primary care practice whose homepage advertises 'GLP-1 and GIP medication programs with personalized nutrition guidance, lifestyle coaching, and ongoing monitoring' — but publishes no price. Visitors are directed to call (505) 420-6979 or email for cost. https://www.reformabq.com(checked 2026-08-28)
Sono Bello (Albuquerque) — 5601 Office Blvd NE, Suite 200, Albuquerque, NM 87109. A national body-contouring chain with a real Albuquerque location; markets 'Post GLP-1 Weight Loss Support' (skin and body contouring after weight loss) rather than GLP-1 prescribing, and lists no semaglutide or tirzepatide price. Included here as evidence that GLP-1-adjacent demand exists in Albuquerque, not as a comparable prescribing provider. https://www.sonobello.com/locations/(checked 2026-08-28)
Frequently asked questions
Does Astra offer semaglutide and tirzepatide in Albuquerque, New Mexico?
Yes. Astra is licensed to treat patients in all 50 states, including New Mexico, and prescribes both semaglutide and tirzepatide through telehealth to Albuquerque residents.
Is Astra cheaper than local Albuquerque GLP-1 clinics?
It's hard to say for certain, because no Albuquerque provider we checked publishes a price. Enhanced Wellness NM and Reform ABQ both market GLP-1 programs but direct patients to call or consult for cost. Astra publishes its price up front: $68/month for semaglutide and $118/month for tirzepatide, both on 12-month plans, the same price for every patient nationwide.
What is the adult obesity rate in Albuquerque and Bernalillo County?
32.9% of Albuquerque adults have obesity (crude prevalence, 2023 BRFSS via CDC PLACES), almost identical to Bernalillo County's 33.0%. Both sit below New Mexico's statewide rate of 34.5% (2024 BRFSS) — Albuquerque is a lower-obesity outlier relative to the rest of the state.
Does New Mexico Medicaid cover semaglutide or tirzepatide for weight loss?
We could not independently verify New Mexico Medicaid's specific coverage of GLP-1 medications for a weight-loss indication, and we're recording that as an open question rather than guessing. Nationally, most state Medicaid programs exclude anti-obesity medications even when they cover the same drugs for diabetes, which is why cash-pay options matter regardless of insurance status.
Do I need a primary care doctor in Albuquerque to get a GLP-1 prescription?
Not through Astra. HRSA designates Bernalillo County's low-income, homeless, and Native American populations as facing a documented primary-care shortage, even though Albuquerque itself isn't a full geographic shortage area — meaning many residents don't have a standing primary-care relationship to start with. Astra's telehealth visits provide the prescription and ongoing monitoring directly, without requiring an existing PCP.